MET and cancer: Several laboratories have been engaged for about thirty years in the detailed study of an oncogene, identified with the acronym “MET”, that is capable of inducing and supporting the uncontrolled growth of cancer cells and—above all—the invasive and metastatic phenotype [1,2].